Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1fd3686cb239172b74cee63622184c3c |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-57581 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K1-065 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575 |
filingDate |
2006-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08685cd3ad6323d727d52fa09319dd43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_718467672ea8b2a0b1179f8f4c42b10a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93832438fcf4fd387b94f12b0e74e0db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b771b4cddccbb9135c4d6f5feca5dc1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cdabf58c22baaef0a5883b76a97a55e |
publicationDate |
2007-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2288118-A1 |
titleOfInvention |
PROCEDURE FOR SYNTHESIZING LYMPHOSINES. |
abstract |
Procedure to synthesize thymosins.n n n Procedure for obtaining thymosins and / ornits pharmaceutically acceptable salts by phase synthesisnsolid on polymeric supports comprising the stages ofnlinearly synthesize the timus derived peptides in phasensolid, incorporate at least one Thr or Ser in the form of a dipeptide ofnpseudoproline in the sequence, obtain the thymosins bynacid peptidyl resin treatmentntrifluoroacetic acid, and purify the thymosins bynRP-HPLC. The present invention also protects thenisolated and / or purified compound obtained by said processnas well as the use of it in the preparation of a medicine. |
priorityDate |
2006-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |